The 7MM soft tissue sarcoma (STS) market is estimated to reach USD 6,465.7 million by 2030 from USD 2,943.3 million in 2019 at a CAGR of 7.4%.

Jane Kelly opened up about the multiple failings of doctors before her teenage daughter Megan was diagnosed with stage 4 cancer and later died of the disease.

Daraine Cunningham's primary school teacher noticed her 'swollen' left eye when she was just nine years old but GPs blamed it ...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted antitumor virotherapies, announced today that the U.S. Food and Drug ...

Eldiara was diagnosed with stage 3 synovial sarcoma, a rare type of soft tissue cancer, when she was just 19 years old – and ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad ...

Greater Manchester 19-year-old Daraine Cunningham's eye had been noticed by teachers back when she was in primary school ...

The boy, named Daoming, has been battling rhabdomyosarcoma — a type of soft tissue sarcoma affecting his brain and nose — for ...

National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced the creation of a new Sarcoma Subcommittee ...

FIVE-year-old Bonnie Spence has been given less than a year to live after doctors mistook her deadly cancer as a ‘broken arm’ ...

Introduction The global Soft Tissue Sarcoma (STS) market has demonstrated significant growth potential, with projections estimating the market to grow at a Compound Annual Growth Rate (CAGR) of 7.4% ...